Fresenius | FRE - Operating Profit

Stock Price
48.99
Daily Change
1.03 2.15%
Monthly
2.73%
Yearly
32.69%
Q1 Forecast
45.82

Fresenius reported EUR574M in Operating Profit for its fiscal quarter ending in September of 2025.





Operating Profit Change Date
Akzo Nobel EUR 297M 6M Sep/2025
Alcon AG USD 332M 85M Sep/2025
AstraZeneca USD -1.5B 5.01B Sep/2025
BASF EUR 493M 334M Sep/2025
Bayer EUR -543M 556M Sep/2025
Beiersdorf EUR 816M 370M Jun/2025
DaVita Healthcare Partners USD 495.6M 34.87M Sep/2025
Demant DKK 1.87B 471M Jun/2025
E.ON EUR 242M 820M Sep/2025
Essilor EUR 2B 1.22B Jun/2025
Fresenius EUR 574M 14M Sep/2025
Fresenius Medical Care EUR 449.94M 18.94M Sep/2025
Getinge SEK 1.08B 900M Dec/2024
Givaudan CHF 364.5M 165.5M Jun/2024
GlaxoSmithKline GBP 2.79B 764M Sep/2025
GN Store Nord DKK 340M 121M Sep/2025
GRIFOLS EUR 352.11M 2.57M Sep/2025
Hikma Pharmaceutical USD 187M 95M Jun/2025
Lonza CHF 430M 104M Dec/2024
Merck EUR 1.21B 180M Sep/2025
Novartis USD 4.5B 363M Sep/2025
Philips EUR 329M 159M Sep/2025
Roche Holding CHF 9.56B 3.8B Dec/2025
RWE EUR 887M 250M Sep/2025
Sanofi EUR 1.7B 2.17B Dec/2025
Smith & Nephew USD 440M 50M Dec/2025